STXS Stereotaxis, Inc. featured news, full reports, and detailed charts
Stereotaxis, Inc. (STXS) Wrap Up:
This annual report on Form 10-K, including the sections entitled “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements. These statements relate to, among other things: • our business strategy; • our value proposition; • the timing and status of review by our collaboration partner of manufacturing and design issues relating to our magnetic irrigated catheter; • the timing and prospects for regulatory approval of our additional disposable interventional devices; • our estimates regarding our capital requirements; • the ability of physicians to perform certain medical procedures with our products safely, effectively and efficiently; ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001193125-08-058487.html#FIS_BUSINESS"Stereotaxis Inc. (STXS:NASDAQ)
Snapshot of Stereotaxis Inc. (STXS)
|
OPEN
$4.06
|
PREVIOUS CLOSE
$3.92
|
|
|
DAY HIGH
$4.07
|
DAY LOW
$3.82
|
|
|
52 WEEK HIGH
08/6/09 - $5.19
|
52 WEEK LOW
01/27/09 - $2.30
|
|
|
MARKET CAP
192.5M
|
AVERAGE VOLUME 3 mo
195.6K
|
|
|
DILUTED EPS TTM
$-0.70
|
SHARES OUTSTANDING
50.3M
|
|
|
STXS Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
related news
STXS Top Compensated Officers
Executives, Board Directors
Key developments for Stereotaxis Inc. (STXS)
Stereotaxis Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company's revenue totaled $13.3 million, an increase of 26% over $10.6 million for the third quarter of 2008. Operating loss was $5.8 million compared with a $10.0 million operating loss in the same period in 2008. The company reported a net loss of $5.8 million, or $0.14 diluted per share. This compared with a net loss of $10.1 million, or $0.28 diluted per share. The increase was due in large part to the issuance of 4.4 million shares as part of two concurrent private placements of stock completed in December 2008. Cash used in operations was $3.5 million compared with $5.5 million in the third quarter of 2008. For the first nine months of 2009, revenue grew 31% to $37.1 million compared with $28.2 million in the first nine months of 2008. Operating loss was $18.0 million compared with a $34.6 million operating loss in the same period in 2008. Net loss was $20.7 million or $0.50 diluted per share compared to $36.3 million or $1.00 diluted per share for the same period a year ago. For the year 2009, the company expects total revenue to exceed 2008 revenue.
Stereotaxis Inc., Q3 2009 Earnings Call, Nov-05 2009
Stereotaxis Inc. expected to Report Fiscal Year 2009 Results on February 26, 2010. This event was calculated by Capital IQ (Created on October 22, 2009).
STXS Competitors
| Company | Last | Change |
| Hansen Medical Inc | $2.70 USD | +0.05 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | STXS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 3.3x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 3.0x |
|
|
STXS |
||
STXS transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
